Tech Company Financing Transactions
Akari Therapeutics Funding Round
Akari Therapeutics closed a $4.5 million funding round on 7/15/2019. Backers included private investors.
Transaction Overview
Company Name
Announced On
7/15/2019
Transaction Type
Venture Equity
Amount
$4,499,945
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 45 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
75-76 Wimpole St.
London, W1G 9RT
UK
London, W1G 9RT
UK
Phone
Email Address
Not Recorded
Overview
Akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Clive Richardson
Browse more venture capital transactions:
Prev: 7/15/2019: Potrero Medical venture capital transaction
Next: 7/15/2019: Larky venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs